Literature DB >> 19710359

Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.

Keiichi Ishihara1, Kenji Amano, Eiichi Takaki, Atsushi Shimohata, Haruhiko Sago, Charles J Epstein, Kazuhiro Yamakawa.   

Abstract

Down syndrome (DS) is the most common cause of mental retardation. Although structural and neurogenic abnormalities have been shown in the brains of DS patients, the molecular etiology is still unknown. To define it, we have performed structural and histological examinations of the brains of Ts1Cje and Ts2Cje, 2 mouse models for DS. These mice carry different length of trisomic segments of mouse chromosome 16 that are orthologous to human chromosome 21. At 3 months of age, ventricular enlargements were observed in both Ts1Cje and Ts2Cje brains at a similar degree. Both mice also showed decreases of the number of doublecortin-positive neuroblasts and thymidine-analog BrdU-labeled proliferating cells in the subventricular zone of the lateral ventricles (LVs) and in the hippocampal dentate gyrus at a similar degree, suggesting impaired adult neurogenesis. Additionally, at embryonic day 14.5, both strains of mice, when compared with diploid littermates, had smaller brains and decreased cortical neurogenesis that could possibly contribute to the ventricular enlargements observed in adulthood. Our findings suggest that the trisomic segment of the Ts1Cje mouse, which is shared with Ts2Cje, contains the genes that are responsible for these abnormal phenotypes and could be relevant to the mental retardation associated with DS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710359     DOI: 10.1093/cercor/bhp176

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  40 in total

1.  DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.

Authors:  Nobuhiro Kurabayashi; Minh Dang Nguyen; Kamon Sanada
Journal:  EMBO Rep       Date:  2015-09-15       Impact factor: 8.807

2.  The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.

Authors:  Faycal Guedj; Jeroen L A Pennings; Millie A Ferres; Leah C Graham; Heather C Wick; Klaus A Miczek; Donna K Slonim; Diana W Bianchi
Journal:  Am J Med Genet A       Date:  2015-05-14       Impact factor: 2.802

3.  Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation.

Authors:  Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Elizabeth Head; Daniel L Gillen
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

Review 4.  Down syndrome: the brain in trisomic mode.

Authors:  Mara Dierssen
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

5.  The RNA-binding protein, ZC3H14, is required for proper poly(A) tail length control, expression of synaptic proteins, and brain function in mice.

Authors:  Jennifer Rha; Stephanie K Jones; Jonathan Fidler; Ayan Banerjee; Sara W Leung; Kevin J Morris; Jennifer C Wong; George Andrew S Inglis; Lindsey Shapiro; Qiudong Deng; Alicia A Cutler; Adam M Hanif; Machelle T Pardue; Ashleigh Schaffer; Nicholas T Seyfried; Kenneth H Moberg; Gary J Bassell; Andrew Escayg; Paul S García; Anita H Corbett
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

6.  A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

Authors:  Tao Yu; Zhongyou Li; Zhengping Jia; Steven J Clapcote; Chunhong Liu; Shaomin Li; Suhail Asrar; Annie Pao; Rongqing Chen; Ni Fan; Sandra Carattini-Rivera; Allison R Bechard; Shoshana Spring; R Mark Henkelman; George Stoica; Sei-Ichi Matsui; Norma J Nowak; John C Roder; Chu Chen; Allan Bradley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2010-05-04       Impact factor: 6.150

Review 7.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 8.  Molecular basis of pharmacotherapies for cognition in Down syndrome.

Authors:  Katheleen J Gardiner
Journal:  Trends Pharmacol Sci       Date:  2009-12-04       Impact factor: 14.819

9.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

10.  Lithium rescues synaptic plasticity and memory in Down syndrome mice.

Authors:  Andrea Contestabile; Barbara Greco; Diego Ghezzi; Valter Tucci; Fabio Benfenati; Laura Gasparini
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.